Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
S2CID 249259033
Heffernan, R
Evidence suggests: Normal telomerase activation cancer risk Key difference: Cancer has multiple mutations beyond telomerase Normalized telomerase in healthy cells appears safe Animal study cancer data: Mechanisms of cancer protection: Immune system enhancement detects and eliminates pre-cancerous cells Antioxidant effects reduce DNA damage (cancer initiation) Normal cell cycle regulation vs dysregulation Apoptosis (programmed cell death) in damaged cells Reduced chronic inflammation (cancer promoter) Important caveats: Animal data doesn't guarantee human cancer prevention No human cancer prevention trials completed Not a substitute for medical cancer screening Should not delay conventional cancer treatment Theoretical benefit needs validation Learn about peptide safety and research at SeekPeptides
Nat Rev Mater 6:351370 Markham A (2021) Tisotumab vedotin: first approval
